Alibaba Health Information Technology Limited

SEHK:241 Stock Report

Market Cap: HK$55.6b

Alibaba Health Information Technology Management

Management criteria checks 3/4

Alibaba Health Information Technology's CEO is Difan Shen, appointed in Nov 2023, has a tenure of 1.08 years. total yearly compensation is CN¥6.81M, comprised of 25.2% salary and 74.8% bonuses, including company stock and options. directly owns 0.009% of the company’s shares, worth HK$4.97M. The average tenure of the management team and the board of directors is 2.3 years and 2.4 years respectively.

Key information

Difan Shen

Chief executive officer

CN¥6.8m

Total compensation

CEO salary percentage25.2%
CEO tenure1.1yrs
CEO ownership0.009%
Management average tenure2.3yrs
Board average tenure2.4yrs

Recent management updates

Recent updates

Alibaba Health Information Technology's (HKG:241) Solid Earnings Have Been Accounted For Conservatively

Dec 19
Alibaba Health Information Technology's (HKG:241) Solid Earnings Have Been Accounted For Conservatively

Earnings Tell The Story For Alibaba Health Information Technology Limited (HKG:241) As Its Stock Soars 30%

Oct 18
Earnings Tell The Story For Alibaba Health Information Technology Limited (HKG:241) As Its Stock Soars 30%

What Does Alibaba Health Information Technology Limited's (HKG:241) Share Price Indicate?

Sep 23
What Does Alibaba Health Information Technology Limited's (HKG:241) Share Price Indicate?

Alibaba Health Information Technology (HKG:241) Is Looking To Continue Growing Its Returns On Capital

Jul 03
Alibaba Health Information Technology (HKG:241) Is Looking To Continue Growing Its Returns On Capital

After Leaping 26% Alibaba Health Information Technology Limited (HKG:241) Shares Are Not Flying Under The Radar

Jun 07
After Leaping 26% Alibaba Health Information Technology Limited (HKG:241) Shares Are Not Flying Under The Radar

Alibaba Health Information Technology's (HKG:241) Solid Earnings Are Supported By Other Strong Factors

Jun 06
Alibaba Health Information Technology's (HKG:241) Solid Earnings Are Supported By Other Strong Factors

Risks Still Elevated At These Prices As Alibaba Health Information Technology Limited (HKG:241) Shares Dive 26%

Apr 21
Risks Still Elevated At These Prices As Alibaba Health Information Technology Limited (HKG:241) Shares Dive 26%

Is Now The Time To Look At Buying Alibaba Health Information Technology Limited (HKG:241)?

Apr 16
Is Now The Time To Look At Buying Alibaba Health Information Technology Limited (HKG:241)?

Alibaba Health Information Technology (HKG:241) Might Have The Makings Of A Multi-Bagger

Mar 29
Alibaba Health Information Technology (HKG:241) Might Have The Makings Of A Multi-Bagger

Is There An Opportunity With Alibaba Health Information Technology Limited's (HKG:241) 36% Undervaluation?

Mar 12
Is There An Opportunity With Alibaba Health Information Technology Limited's (HKG:241) 36% Undervaluation?

With A 25% Price Drop For Alibaba Health Information Technology Limited (HKG:241) You'll Still Get What You Pay For

Jan 17
With A 25% Price Drop For Alibaba Health Information Technology Limited (HKG:241) You'll Still Get What You Pay For

Is Now An Opportune Moment To Examine Alibaba Health Information Technology Limited (HKG:241)?

Jan 07
Is Now An Opportune Moment To Examine Alibaba Health Information Technology Limited (HKG:241)?

CEO Compensation Analysis

How has Difan Shen's remuneration changed compared to Alibaba Health Information Technology's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

CN¥1b

Jun 30 2024n/an/a

CN¥1b

Mar 31 2024CN¥7mCN¥2m

CN¥883m

Dec 31 2023n/an/a

CN¥851m

Sep 30 2023n/an/a

CN¥819m

Jun 30 2023n/an/a

CN¥678m

Mar 31 2023CN¥6mCN¥1m

CN¥536m

Dec 31 2022n/an/a

CN¥332m

Sep 30 2022n/an/a

CN¥128m

Jun 30 2022n/an/a

-CN¥69m

Mar 31 2022CN¥6mCN¥1m

-CN¥266m

Dec 31 2021n/an/a

-CN¥216m

Sep 30 2021n/an/a

-CN¥167m

Jun 30 2021n/an/a

CN¥91m

Mar 31 2021n/an/a

CN¥349m

Dec 31 2020n/an/a

CN¥313m

Sep 30 2020n/an/a

CN¥278m

Jun 30 2020n/an/a

CN¥136m

Mar 31 2020CN¥12mCN¥2m

-CN¥7m

Dec 31 2019n/an/a

-CN¥3m

Sep 30 2019n/an/a

CN¥1m

Jun 30 2019n/an/a

-CN¥40m

Mar 31 2019CN¥7mCN¥33k

-CN¥82m

Compensation vs Market: Difan's total compensation ($USD933.67K) is about average for companies of similar size in the Hong Kong market ($USD788.91K).

Compensation vs Earnings: Difan's compensation has been consistent with company performance over the past year.

CEO

Difan Shen (46 yo)

1.1yrs

Tenure

CN¥6,814,000

Compensation

Mr. Difan Shen serves as Chief Executive Officer of Alibaba Health Information Technology Limited from November 28, 2023 and serves as Executive Director since October 13, 2021. He was Chief Operating Offi...

Leadership Team

NamePositionTenureCompensationOwnership
Difan Shen
CEO & Executive Director1.1yrsCN¥6.81m0.0089%
HK$ 5.0m
Yanwu Tu
CFO & Executive Director4.7yrsCN¥5.34m0.0050%
HK$ 2.8m
Hiu Leong Tsui
Legal Counsel & Joint Company Secretary1.9yrsno datano data
Yin Rui
Chief Marketing Officer2.8yrsno datano data
Zhang Hua
Chief People Officer4.8yrsno datano data
Chun Chung Kwong
Financial Controllerno datano datano data
Deng Yan
Chief Legal Advisor & Joint Company Secretary1.3yrsno datano data

2.3yrs

Average Tenure

Experienced Management: 241's management team is considered experienced (2.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Difan Shen
CEO & Executive Director3.2yrsCN¥6.81m0.0089%
HK$ 5.0m
Yanwu Tu
CFO & Executive Director4.2yrsCN¥5.34m0.0050%
HK$ 2.8m
Yihong Wu
Independent Non-Executive Director1.3yrsCN¥411.00kno data
Yi Fei Huang
Independent Non-Executive Director5.5yrsCN¥348.00kno data
Shunyan Zhu
Non-Executive Chairman of the Board4.8yrsCN¥19.00m0.0086%
HK$ 4.8m
Rong Shao
Independent Non-Executive Director1.3yrsCN¥223.00kno data
Jiaojiao Huang
Non-Executive Director1.6yrsno datano data
Haipeng Xu
Non-Executive Director1.2yrsno datano data

2.4yrs

Average Tenure

48.5yo

Average Age

Experienced Board: 241's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 09:12
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Alibaba Health Information Technology Limited is covered by 30 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Xiaomeng ZhuangBofA Global Research
Shun Kei LawCCB International Securities Limited
Hazim BahariCFRA Equity Research